EUVIMEDEUVIMED entdecken
Crossref

Is Placebo Still Ethical in Trials of Incretin Therapies?

Brendon L Neuen iD, John W Ostrominski iD, Muthiah Vaduganathan iD

Circulation · 07.04.2026 · 153 (14) · 1005-1008

DOI: 10.1161/circulationaha.125.077277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 07.04.2026. Verfasst von Brendon L Neuen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia (B.L.N.). Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GLP-1 receptor agonistsclinical trialheart failurekidney diseasesobesity

Autor:innen und Institutionen

  • Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia (B.L.N.).
  • Department of Renal Medicine, Royal North Shore Hospital, Sydney, NSW, Australia (B.L.N.).
  • Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.W.O., M.V.).

ORCID-Profile: Brendon L Neuen, John W Ostrominski, Muthiah Vaduganathan

Zitieren

APA

Neuen, B. L., Ostrominski, J. W., & Vaduganathan, M. (2026). Is Placebo Still Ethical in Trials of Incretin Therapies?. Circulation, 153(14), 1005-1008. https://doi.org/10.1161/circulationaha.125.077277

Vancouver

Neuen BL, Ostrominski JW, Vaduganathan M. Is Placebo Still Ethical in Trials of Incretin Therapies?. Circulation. 2026;153(14):1005-1008. doi:10.1161/circulationaha.125.077277

BibTeX
@article{Neuen2026,
  author = {Neuen, Brendon L and Ostrominski, John W and Vaduganathan, Muthiah},
  title = {Is Placebo Still Ethical in Trials of Incretin Therapies?},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {14},
  pages = {1005--1008},
  doi = {10.1161/circulationaha.125.077277}
}
Kostenlos starten →